169 related articles for article (PubMed ID: 30554726)
21. Attenuation of postmenopausal bone loss in patients with transient hypoparathyroidism after total thyroidectomy.
Takamura Y; Miyauchi A; Yabuta T; Kihara M; Ito Y; Miya A
World J Surg; 2013 Dec; 37(12):2860-5. PubMed ID: 24045966
[TBL] [Abstract][Full Text] [Related]
22. Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma.
Reverter JL; Holgado S; Alonso N; Salinas I; Granada ML; Sanmartí A
Endocr Relat Cancer; 2005 Dec; 12(4):973-81. PubMed ID: 16322336
[TBL] [Abstract][Full Text] [Related]
23. Bone microstructure of adult patients with non-surgical hypoparathyroidism assessed by high-resolution peripheral quantitative computed tomography.
Liu J; Chen S; Quan T; Wang Y; Wang O; Nie M; Jiang Y; Li M; Xing X; Xia W
Osteoporos Int; 2020 Nov; 31(11):2219-2230. PubMed ID: 32623488
[TBL] [Abstract][Full Text] [Related]
24. Effects of TSH suppressive therapy on bone mineral density (BMD) and bone turnover markers (BTMs) in patients with differentiated thyroid cancer in Northeast China: a prospective controlled cohort study.
Wang S; Wang Y; Zhu L; He L; Lv M; Zhang H; Wang H; Zhang F; Lai Y; Li Y; Shan Z; Teng W
Endocrine; 2023 Jan; 79(1):113-124. PubMed ID: 36089636
[TBL] [Abstract][Full Text] [Related]
25. Features of patients and fracture risk in hypoparathyroidism; a single center study.
Slutzky-Shraga I; Hirsch D; Gorshtein A; Masri-Iraqi H; Shochat T; Robenshtok E; Shimon I; Tsvetov G
J Endocrinol Invest; 2024 Mar; 47(3):593-601. PubMed ID: 37610611
[TBL] [Abstract][Full Text] [Related]
26. Long-term thyroxine treatment and bone mineral density.
Franklyn JA; Betteridge J; Daykin J; Holder R; Oates GD; Parle JV; Lilley J; Heath DA; Sheppard MC
Lancet; 1992 Jul; 340(8810):9-13. PubMed ID: 1351654
[TBL] [Abstract][Full Text] [Related]
27. Volumetric bone mineral density and bone geometry assessed by peripheral quantitative computed tomography in women with differentiated thyroid cancer under TSH suppression.
Tournis S; Antoniou JD; Liakou CG; Christodoulou J; Papakitsou E; Galanos A; Makris K; Marketos H; Nikopoulou S; Tzavara I; Triantafyllopoulos IK; Dontas I; Papaioannou N; Lyritis GP; Alevizaki M
Clin Endocrinol (Oxf); 2015 Feb; 82(2):197-204. PubMed ID: 25040693
[TBL] [Abstract][Full Text] [Related]
28. Bone changes in pre- and postmenopausal women with thyroid cancer on levothyroxine therapy: evolution of axial and appendicular bone mass.
Jódar E; Begoña López M; García L; Rigopoulou D; Martínez G; Hawkins F
Osteoporos Int; 1998; 8(4):311-6. PubMed ID: 10024900
[TBL] [Abstract][Full Text] [Related]
29. High peripheral and axial bone densities in a postmenopausal woman with untreated hypoparathyroidism.
Orr-Walker B; Harris R; Holdaway IM; Foote G; Reid IR
Postgrad Med J; 1990 Dec; 66(782):1061-3. PubMed ID: 2084655
[TBL] [Abstract][Full Text] [Related]
30. Thyroxine suppressive therapy decreases bone mineral density in post-menopausal women.
Kung AW; Lorentz T; Tam SC
Clin Endocrinol (Oxf); 1993 Nov; 39(5):535-40. PubMed ID: 8252741
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of trabecular bone score in patients with a distal radius fracture.
Shin YH; Gong HS; Gang DH; Shin HS; Kim J; Baek GH
Osteoporos Int; 2016 Dec; 27(12):3559-3565. PubMed ID: 27341808
[TBL] [Abstract][Full Text] [Related]
32. Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine.
Karner I; Hrgović Z; Sijanović S; Buković D; Klobucar A; Usadel KH; Fassbender WJ
Eur J Med Res; 2005 Nov; 10(11):480-8. PubMed ID: 16354602
[TBL] [Abstract][Full Text] [Related]
33. Bone mass in totally thyroidectomized patients. Role of calcitonin deficiency and exogenous thyroid treatment.
Gonzalez DC; Mautalen CA; Correa PH; el Tamer E; el Tamer S
Acta Endocrinol (Copenh); 1991 May; 124(5):521-5. PubMed ID: 2028710
[TBL] [Abstract][Full Text] [Related]
34. The Effects of Radioiodine Therapy on the Recovery of Parathyroid Function in Patients with Protracted Hypoparathyroidism after Total Thyroidectomy for Papillary Thyroid Carcinoma.
Abuduwaili M; Baidula W; Xia B; Wu Z; Chen Z; Xing Z; Su A
J Invest Surg; 2023 Dec; 36(1):1-9. PubMed ID: 36410743
[TBL] [Abstract][Full Text] [Related]
35. Relationship between bone turnover biomarkers, mandibular bone mineral density, and systemic skeletal bone mineral density in premenopausal and postmenopausal Indian women.
Makker A; Singh MM; Mishra G; Singh BP; Jain GK; Jadhav S
Menopause; 2012 Jun; 19(6):642-9. PubMed ID: 22240638
[TBL] [Abstract][Full Text] [Related]
36. The Effect of TSH Suppression on Vertebral Trabecular Bone Scores in Patients With Differentiated Thyroid Carcinoma.
Moon JH; Kim KM; Oh TJ; Choi SH; Lim S; Park YJ; Park DJ; Jang HC
J Clin Endocrinol Metab; 2017 Jan; 102(1):78-85. PubMed ID: 27754806
[TBL] [Abstract][Full Text] [Related]
37. Endocrine Complications of Surgical Treatment of Thyroid Cancer: An Update.
Iglesias P; Díez JJ
Exp Clin Endocrinol Diabetes; 2017 Sep; 125(8):497-505. PubMed ID: 28444664
[TBL] [Abstract][Full Text] [Related]
38. Determination of bone mineral density by quantitative computed tomography and single photon absorptiometry in subclinical hyperthyroidism: a risk of early osteopaenia in post-menopausal women.
Lehmke J; Bogner U; Felsenberg D; Peters H; Schleusener H
Clin Endocrinol (Oxf); 1992 May; 36(5):511-7. PubMed ID: 1617803
[TBL] [Abstract][Full Text] [Related]
39. Attenuation of postmenopausal high turnover bone loss in patients with hypoparathyroidism.
Fujiyama K; Kiriyama T; Ito M; Nakata K; Yamashita S; Yokoyama N; Nagataki S
J Clin Endocrinol Metab; 1995 Jul; 80(7):2135-8. PubMed ID: 7608266
[TBL] [Abstract][Full Text] [Related]
40. Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone.
Sijanovic S; Karner I
Medscape Womens Health; 2001 Oct; 6(5):3. PubMed ID: 11698925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
